NEW TRADES SECRET LAW COULD BLOCK CLINICAL TRIAL INFORMATION EXCHANGE CLAIMS EPHA
May 1st, 2016
THE EUROPEAN Public Health Alliance (EPHA) has raised concerns that a new proposed European Union (EU) directive on trade secrets will undermine recently introduced rights to explore EU clinical trial data. EPHA was commenting after the European Parliament approved the new legislation (on April 14), which introduces an EU-wide definition of ‘trade secret’ and obliges EU member states to ensure that victims of misuse of trade secrets can defend their rights in court and to seek compensation. The agreed law also lays down rules to protect confidential ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.